Fig. 1
Mean change for SDS total (a) and domain (b) scores from baseline to 6-weeks by treatment group. Lurasidone vs. Placebo: *p < 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001
Fig. 1 | International Journal of Bipolar Disorders
Mean change for SDS total (a) and domain (b) scores from baseline to 6-weeks by treatment group. Lurasidone vs. Placebo: *p < 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001